dpp-4 inhibitors and glp-1 agonists together Differences between receptor GLP-1-based therapies: current knowledge of

Monomeric C-reactive protein: current perspectives for utilization and inclusion as a prognostic indicator and therapeutic target

First, Sensing and Destruction: COFs, equipped with precisely integrated sensitizing units, efficiently respond to external stimuli (e.g., light, ultrasound, radiation) or endogenous triggers (e.g., H 2 O 2 ), generating intense local biochemical effects such as bursts of ROS, hyperthermia, or DNA damage ( Figure 2 ) (155, 156, 166)

Cytochrome c, a soluble protein localized on the IMM, contains a single heme group

Metabolic & Hepatic Benefits Tesamorelin improves lipid profiles and reduces liver fat accumulation, supporting metabolic health beyond simple weight reduction

up to half of them normalize the PRL level (244)